[go: up one dir, main page]

BR9814042A - "compostos de tiofeno condensados e seu uso farmacêutico" - Google Patents

"compostos de tiofeno condensados e seu uso farmacêutico"

Info

Publication number
BR9814042A
BR9814042A BR9814042-6A BR9814042A BR9814042A BR 9814042 A BR9814042 A BR 9814042A BR 9814042 A BR9814042 A BR 9814042A BR 9814042 A BR9814042 A BR 9814042A
Authority
BR
Brazil
Prior art keywords
compound
pharmaceutical use
condensed
useful
formula
Prior art date
Application number
BR9814042-6A
Other languages
English (en)
Inventor
Koji Seio
Hiroshi Tanaka
Toshiyuki Kohara
Kenji Hashimoto
Masatake Fujimura
Hideki Horiuchi
Hiroshi Yasumatsu
Koreichi Kimura
Original Assignee
Yoshitomi Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27322564&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9814042(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Yoshitomi Pharmaceutical filed Critical Yoshitomi Pharmaceutical
Publication of BR9814042A publication Critical patent/BR9814042A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Patente de Invenção: <B>"COMPOSTOS DE TIOFENO CONDENSADOS E SEU USO FARMACêUTICO"<D>. Composto tiofeno condensado da fórmula (I) onde cada símbolo é conforme acima definido no relatório, um seu sal farmaceuticamente aceitável e seus hidratos. O composto da fórmula (I) da presente invenção é útil como um novo agente psicótico que é eficaz para ambos os sintomas positivos e sintomas negativos ou esquizofrenia, o qual está associado com menos efeitos colaterais tal como distúrbio motor extrapiramidal e similar e que está menos associado com sérios efeitos colaterais tal como agranulocitose e similar. Em adição, este composto é também útil como um agente terapêutico da doença de Alzheimer e doença maníaco-depressiva.
BR9814042-6A 1997-09-02 1999-07-08 "compostos de tiofeno condensados e seu uso farmacêutico" BR9814042A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP23670097 1997-09-02
JP27777197 1997-10-09
JP16572598 1998-06-12
PCT/JP1998/003915 WO1999011647A1 (en) 1997-09-02 1998-08-31 Fused thiophene compounds and medicinal use thereof

Publications (1)

Publication Number Publication Date
BR9814042A true BR9814042A (pt) 2000-10-03

Family

ID=27322564

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9814042-6A BR9814042A (pt) 1997-09-02 1999-07-08 "compostos de tiofeno condensados e seu uso farmacêutico"

Country Status (16)

Country Link
US (2) US6271225B1 (pt)
EP (1) EP1016664B1 (pt)
JP (2) JP3156933B2 (pt)
KR (1) KR20010021989A (pt)
CN (1) CN1268949A (pt)
AT (1) ATE244245T1 (pt)
AU (1) AU739385B2 (pt)
BR (1) BR9814042A (pt)
CA (1) CA2302409A1 (pt)
DE (1) DE69816102D1 (pt)
HU (1) HUP0003718A3 (pt)
IL (1) IL134812A0 (pt)
NO (1) NO20001049L (pt)
NZ (1) NZ503484A (pt)
RU (1) RU2197491C2 (pt)
WO (1) WO1999011647A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1171447A2 (en) 1999-04-16 2002-01-16 Ortho-McNeil Pharmaceutical, Inc. Ketolide antibacterials
US6590083B1 (en) 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
US6608053B2 (en) * 2000-04-27 2003-08-19 Yamanouchi Pharmaceutical Co., Ltd. Fused heteroaryl derivatives
US6751036B2 (en) * 2000-08-04 2004-06-15 Seagate Technology Llc Tuning track density for data storage device
US8329924B2 (en) * 2001-06-11 2012-12-11 Vertex Pharmaceuticals (Canada) Incorporated Compounds and methods for the treatment or prevention of Flavivirus infections
EA007484B1 (ru) * 2001-06-11 2006-10-27 Вирокем Фарма Инк. Соединения и способы лечения или предупреждения инфекций flavivirus
WO2004014895A1 (en) * 2002-08-05 2004-02-19 Eli Lilly And Company Piperazine substituted aryl benzodiazepines
US7402608B2 (en) 2002-12-10 2008-07-22 Virochem Pharma Inc. Compounds and methods for the treatment or prevention of Flavivirus infections
US20040236181A1 (en) * 2003-04-01 2004-11-25 Olympus Corporation In-body information acquiring apparatus and power-supply circuit
WO2005026177A1 (en) * 2003-09-09 2005-03-24 Eli Lilly And Company Substituted piperazines of azepines, oxazepines, and thiazepines
RU2248205C1 (ru) * 2003-09-18 2005-03-20 Открытое акционерное общество "Щелковский витаминный завод" Лекарственное средство в виде желатиновой капсулы
EP1713486A4 (en) * 2003-12-02 2009-04-29 Sheldon Leslie James COMBINED THERAPY FOR THE TREATMENT OF DEMENTIA, DEPRESSION AND APATHY
WO2005063771A1 (en) * 2003-12-22 2005-07-14 Teva Pharmaceutical Industries Ltd Methods of preparing olanzapine
US7807828B2 (en) * 2005-08-11 2010-10-05 Hypnion, Inc. Olanzapine analogs and methods of use thereof
CN101568538B (zh) 2006-11-15 2012-09-05 Viro化学制药公司 用于治疗或预防黄病毒属感染的噻吩类似物
PL395468A1 (pl) 2011-06-29 2013-01-07 Adamed Spólka Z Ograniczona Odpowiedzialnoscia Zwiazki amidoalkilopiperazynylowe do leczenia chorób osrodkowego ukladu nerwowego
JP6551671B2 (ja) * 2015-08-11 2019-07-31 国立大学法人 熊本大学 アルツハイマー治療薬
US12365696B2 (en) 2019-05-10 2025-07-22 Dana-Farber Cancer Institute, Inc. Small-molecule focal adhesion kinase (FAK) inhibitors

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL140242B (nl) 1963-03-01 1973-11-15 Wander Ag Dr A Werkwijze voor het bereiden van op de 11-plaats door een basische groep gesubstitueerde dibenz (b.f.)(1.4) oxazepinen.
CH468400A (de) 1965-12-23 1969-02-15 Sandoz Ag Verfahren zur Herstellung neuer Thieno(2,3-b)(1,5)benzothiazepin-4-on-Verbindungen
US3726977A (en) 1969-02-06 1973-04-10 Sandoz Ag 2-NITRO-11-(1-PIPERAZINYL)-DIBENZ (b,f) (1,4) OXAZEPINES COMPOSITIONS IN THE TREATMENT OF DEPRESSION
US3683084A (en) 1969-02-06 1972-08-08 Jean Schmutz Basically substituted heterocycles as anti-emetics
US3962248A (en) * 1972-04-04 1976-06-08 Sandoz, Inc. Process for making 11-piperazino-diazepines, oxazepines, thiazepines and azepines
US4172831A (en) 1974-11-26 1979-10-30 Lilly Industries Limited Thieno-benzodiazepines
SU629879A3 (ru) * 1974-11-26 1978-10-25 Лилли Индастриз Лимитед, (Фирма) Способ получени тиено(1,5) бензодиазепинов или их солей
US4115568A (en) 1974-11-26 1978-09-19 Lilly Industries Limited Thieno[3,2-b]-[1,5]benzodiazepines
GB1533236A (en) * 1975-11-24 1978-11-22 Lilly Industries Ltd Thieno(1,5)benzodiazepine intermediates
US4157444A (en) 1978-03-13 1979-06-05 American Cyanamid Company 10-(Piperazinyl)thieno[3,4-b][1,5]benzoxazepines and 10-(piperazinyl)thieno[3,4-b][1,5]benzothiazepines
GB9009229D0 (en) * 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds
US5538965A (en) 1993-12-23 1996-07-23 Allelix Biopharmaceuticals Inc. Dopamine receptor ligands
US5602124A (en) 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. 5-HT2 receptor ligands
US5576314A (en) 1994-12-12 1996-11-19 Allelix Biopharmaceuticals Inc. Bicyclic nonane and decane compounds having dopamine receptor affinity
US5602120A (en) 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. Benzyl-substituted compounds having dopamine receptor affinity
US5602121A (en) 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. Alkyl-substituted compounds having dopamine receptor affinity
US5700445A (en) 1994-12-12 1997-12-23 Allelix Biopharmaceuticals, Inc. N-methyl piperazine compounds having dopamine receptor affinity
US5561127A (en) 1994-12-19 1996-10-01 Allelix Biopharmaceuticals, Inc. Muscarinic receptor ligands

Also Published As

Publication number Publication date
AU739385B2 (en) 2001-10-11
EP1016664B1 (en) 2003-07-02
AU8889098A (en) 1999-03-22
ATE244245T1 (de) 2003-07-15
EP1016664A4 (en) 2001-01-24
RU2197491C2 (ru) 2003-01-27
HUP0003718A2 (hu) 2001-09-28
WO1999011647A1 (en) 1999-03-11
US6455521B1 (en) 2002-09-24
NO20001049L (no) 2000-04-03
CA2302409A1 (en) 1999-03-11
JP3156933B2 (ja) 2001-04-16
DE69816102D1 (de) 2003-08-07
IL134812A0 (en) 2001-04-30
KR20010021989A (ko) 2001-03-15
HUP0003718A3 (en) 2002-11-28
NZ503484A (en) 2001-10-26
JP2001072684A (ja) 2001-03-21
US20020042411A1 (en) 2002-04-11
EP1016664A1 (en) 2000-07-05
JP4354106B2 (ja) 2009-10-28
US6271225B1 (en) 2001-08-07
NO20001049D0 (no) 2000-03-01
CN1268949A (zh) 2000-10-04

Similar Documents

Publication Publication Date Title
BR9814042A (pt) &#34;compostos de tiofeno condensados e seu uso farmacêutico&#34;
BR0205684A (pt) Compostos cìclicos fundidos e seu uso medicinal
BR0208891A (pt) Derivados de dihidro-benzo[b]-[1,4]diazepin-2-ona como antagonistas de mglur2 ii
BRPI0418148A (pt) composto, prodroga de um composto, modulador da função do receptor gpr40, agente farmacêutico, uso de um composto e métodos de modificação de uma função do receptor gpr40 em um mamìfero, de profilaxia ou tratamento de diabetes em um mamìfero e de produção de um composto
BR0213612A (pt) Composto, composição farmacêutica, uso do composto e método para tratamento de doença ou condição
BRPI0407618A (pt) derivados de tiazole amino substituidos com cicloalquilo contendo n e composições farmacêuticas para inibição da proliferação celular e métodos para a sua utilização
BR9915967A (pt) Derivados de propanolamina substituìdos por arila, proceso para sua preparação, medicamentos contendo estes compostos e seu uso
BR9911779A (pt) Benzotiofenos, benzofuranos e indóis úteis no tratamento de resistência à insulina e hiperglicemia
BR0211742A (pt) Derivados de aminoisoxazole ativos como inibidores de cinase
DK0562512T3 (da) Sulfonamidocarbonylpyridin-2-carboxylsyreamider samt deres anvendelse som lægemidler
BRPI0112986B8 (pt) compostos azabicíclicos, processo para a sua preparação, bem como composições farmacêuticas compreendendo os ditos compostos
BR0212008A (pt) Uso de um composto ou de um sal, solvato ou pró-medicamento deste, composição farmacêutica, composto ou um sal, solvato ou pró-medicamento deste, e, processo para a preparação deste
KR950700060A (ko) 운동 뉴우런 질병의 치료에 유용한 약품을 얻기 위한 2-아미노-6-트리플루오로메톡시 벤조티아졸(리루졸)의 사용(Application of 2-amino 6-trifluoromethoxy benzothiazole(riluzole) for obtaining a drug useful in the treatment of motor neuron diseases)
BR0111913A (pt) Análogos de gabapentina para distúrbios do sono
BRPI0417948A (pt) derivados de quinuclidina substituìda por bicicloheterociclo fundido
BR0211995A (pt) Preparados de combinação de derivados de propanolamina substituìdos por arila com outras substâncias ativas e sua aplicação
BR9914266A (pt) Derivados de propanolamina substituìdos por heterociclos, processos para a sua preparação, medicamentos contendo estes compostos e seu emprego
BR0010802A (pt) Antagonistas de receptor il-8
BR0113590A (pt) 7-oxo-piridopirimidinas
KR900002777A (ko) 정신분열증 및 정신병 치료 또는 예방제
BR0107493A (pt) Substâncias para uso no tratamento de psorìase
BR0211265A (pt) Derivados de fenilacetamido-tiazol, processo para sua preparação e o seu uso como agentes antitumor
BR0010151A (pt) Inibidores do sistema de clivagem de glicina como antipsicóticos potenciais
BRPI0413013A (pt) composto, seus sais, solvatos, e derivados farmaceuticamente funcionais, composição farmacêutica, uso de um composto, e, métodos para o tratamento ou profilaxia de condições ou distúrbios, e de doenças
BR9914929A (pt) Fenil - alquenoil - guanidinas substituìdas de ácido biliar, processos para a sua preparação, sua aplicação como medicamentos ou agentes diagnósticos, assim como medicamento contendo as mesmas

Legal Events

Date Code Title Description
TC Change of name
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A,7A,8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1910 DE 14/08/2007.